Bayocot, Lani P.
HRN: 23-69-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2023
CEFUROXIME 500MG (TAB)
10/16/2023
10/22/2023
PO
500mg
BID
S/p Vaginal Hysterectomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes